LIVN LivaNova
WatchlistLivaNova News
LivaNova Says Hit by Cybersecurity Incident, Disrupting Operations; Shares Drop Early
LivaNova (LIVN) said in a regulatory filing late Monday that a "cybersecurity incident" disrupted parts of its information technology systems and is expected to cause continued disruptions to its busi
LivaNova (LIVN) Receives a Buy From Stifel Nicolaus
What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate?
LivaNova PLC (NASDAQ:LIVN), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$57.80 a
LivaNova to Present at the Piper Sandler Healthcare Conference
LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Bill Kozy, Interim Chief Executive Officer and Board Cha
Analysts Conflicted on These Healthcare Names: LivaNova (LIVN), Immutep (IMMP) and Nurix Therapeutics (NRIX)
LivaNova's Q3 Beat and Future Outlook: Balancing Strong Cardiopulmonary Performance With Inflation Concerns and Leadership Transition
LivaNova PLC (NASDAQ:LIVN) Q3 2023 Earnings Call Transcript
LivaNova Sees FY23 Revenue Growth Up 9%-11% On Constant-Currency Basis
LivaNova Sees FY23 Revenue Growth Up 9%-11% On Constant-Currency Basis
LivaNova Sees FY23 Adj EPS $2.60-$2.80 Vs $2.66 Est.
LivaNova Sees FY23 Adj EPS $2.60-$2.80 Vs $2.66 Est.
Earnings Scheduled For November 1, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion. • Ballys (NYSE:BALY) is estimated to report quarterly loss
LivaNova Q3 2023 Adj EPS $0.73 Beats $0.64 Estimate, Sales $286.10M Beat $273.42M Estimate
LivaNova (NASDAQ:LIVN) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.64 by 14.06 percent. This is a 25.86 percent increase over earnings of $0.58 per s
Earnings Outlook For LivaNova
LivaNova (NASDAQ:LIVN) is set to give its latest quarterly earnings report on Wednesday, 2023-11-01. Here's what investors need to know before the announcement.Analysts estimate that LivaNova will rep
Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal
If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? Typically, we'll see the trend of both return on capital employed (ROCE) declining and thi
LivaNova to Present at the Stifel and Wolfe Healthcare Conferences
LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Bill Kozy, Interim Chief Executive Officer and Board Cha
5 Analysts Have This to Say About LivaNova
Within the last quarter, LivaNova (NASDAQ:LIVN) has observed the following analyst ratings: BullishSomewhat BullishIndifferentSomewhat BearishBearishTotal Ratings21200Last 30D100001M Ago000002M Ago001
Walgreens To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page B of A Secu
Needham Maintains Buy on LivaNova, Lowers Price Target to $62
Needham analyst Mike Matson maintains LivaNova with a Buy and lowers the price target from $71 to $62.
LivaNova Adds Former NuVasive CEO to Its Board
LivaNova Board Appoints J. Christopher Barry as New Director
Long-time Director Andrea Saia to retire from the Board LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, announced its Board of Directors has appointed J. Christopher Barry to the Board,
Further Weakness as LivaNova (NASDAQ:LIVN) Drops 4.2% This Week, Taking Five-year Losses to 54%
Generally speaking long term investing is the way to go. But that doesn't mean long term investors can avoid big losses. For example, after five long years the LivaNova PLC (NASDAQ:LIVN) share price